Pathology Test Details

Item Details
Laboratory RPAH : Molecular Haematology - NSW
Test Name AML-ETO minimal residual disease
Genes Tested RUNX1/RUNX1T1
Test Description Quantitative reverse transcriptase PCR for RUNX1/RUNX1T1 (AML1/ETO) rearrangements associated with acute myeloid leukaemia (AML) and t(8;21); suitable for minimal residual disease monitoring
Method Taqman quantitative reverse transcriptase PCR
Test Type single
Test Accreditation Included In NATA Scope
Clinical Context Somatic mutation
Sample Required Bone marrow in EDTA
Turn Around Time 4 weeks
Medicare Rebate MBS rebate may be available
Pathology Test Last Edit Date 18/08/2017 5:43:31 AM
Go Back
Site Statistics
No. of genes : 2899
No. of labs : 38
No. of tests : 5376

Page last updated:

Copyright © 2022 RCPA. All rights reserved.